Robert L. Davis
Impact in
- Health top 0.2%
- Vaccine Coverage and Hesitancy
- Molecular Biology top 0.2%
- Muscle Physiology and Disorders
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Pluripotent Stem Cells Research
- Genomics and Chromatin Dynamics
- Developmental Biology and Gene Regulation
Papers in
- Epidemiology 55
- Influenza Virus Research Studies 16
-
- Muscle Physiology and Disorders 14
- Ubiquitin and proteasome pathways 11
- RNA Research and Splicing 11
- Co-authors
- Harold Weintraub (11 shared papers)Andrew B. Lassar (13 shared papers)David L. Turner (4 shared papers)Daniel Lockshon (4 shared papers)Robert Benezra (3 shared papers)Stephen J. Tapscott (8 shared papers)Mathew J. Thayer (4 shared papers)Frank DeStefano (18 shared papers)
- Journals
- PEDIATRICS (27 papers)Pharmacoepidemiology and Drug Safety (18 papers)Vaccine (8 papers)Science (7 papers)The Pediatric Infectious Disease Journal (7 papers)
- Partner nations
- United StatesCanadaThailand
In The Last Decade
Robert L. Davis
301 papers receiving 26.0k citations
Robert L. Davis's Hit Papers
Peers
Comparison fields: 5 of 203
- Health 1.4k
- Molecular Biology 11.8k
- Applied Microbiology and Biotechnology 291
- Aging 267
- Toxicology 461
Countries citing papers authored by Robert L. Davis
This map shows the geographic impact of Robert L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Davis more than expected).
Fields of papers citing papers by Robert L. Davis
This network shows the impact of papers produced by Robert L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Davis. The network helps show where Robert L. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 312 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of a single transfected cDNA converts fibroblasts to myoblasts Hit paper breakdown → | 1987 | 2949 |
| 2 | The protein Id: A negative regulator of helix-loop-helix DNA binding proteins Hit paper breakdown → | 1990 | 2037 |
| 3 | The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage Hit paper breakdown → | 1991 | 1464 |
| 4 | Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Hit paper breakdown → | 1989 | 861 |
| 5 | Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children Hit paper breakdown → | 2000 | 858 |
| 6 | MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer Hit paper breakdown → | 1989 | 806 |
| 7 | Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo Hit paper breakdown → | 1991 | 797 |
| 8 | MyoD1: A Nuclear Phosphoprotein Requiring a Myc Homology Region to Convert Fibroblasts to Myoblasts Hit paper breakdown → | 1988 | 761 |
| 9 | The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation Hit paper breakdown → | 1990 | 736 |
| 10 | Reducing Antibiotic Use in Children: A Randomized Trial in 12 Practices Hit paper breakdown → | 2001 | 592 |
| 11 | 1989 | 449 | |
| 12 | 2004 | 443 | |
| 13 | Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study Hit paper breakdown → | 2012 | 427 |
| 14 | 2006 | 399 | |
| 15 | 2015 | 349 | |
| 16 | 2001 | 323 | |
| 17 | 1991 | 311 | |
| 18 | 2002 | 307 | |
| 19 | 1997 | 300 | |
| 20 | 2001 | 299 |
About Robert L. Davis
Robert L. Davis is a scholar working on Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Health, having authored 312 papers that have together received 27.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (16 papers), Muscle Physiology and Disorders (14 papers), Vaccine Coverage and Hesitancy (14 papers), Ubiquitin and proteasome pathways (11 papers), RNA Research and Splicing (11 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Hemoglobinopathies and Related Disorders (8 papers). The work is most often cited by research in Health (1.4k citations), Molecular Biology (11.8k citations), Applied Microbiology and Biotechnology (291 citations), Aging (267 citations) and Toxicology (461 citations). Robert L. Davis has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Harold Weintraub, Andrew B. Lassar, David L. Turner, Daniel Lockshon, Robert Benezra, Stephen J. Tapscott, Mathew J. Thayer, Frank DeStefano, Richard Platt and Steven Black. Their work appears in journals such as PEDIATRICS, Pharmacoepidemiology and Drug Safety, Vaccine, Science and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.